Pharmacologic treatment of pediatric asthma. Consider disease severity as well as delivery method.
Marshik
Patricia L
PL
University of New Mexico College of Pharmacy, Albuquerque, USA.
D000280:Administration, Inhalation; D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000328:Adult; D000367:Age Factors; D000465:Algorithms; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000145:classification; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001249:Asthma / Q000145:classification / Q000188:drug therapy* / Q000451:nursing; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002648:Child; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage; D009330:Nebulizers and Vaporizers; D009722:Nurse Practitioners; D010347:Patient Care Planning; D010353:Patient Education as Topic; D018579:Patient Selection; D010371:Pediatric Nursing / Q000379:methods; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods / Q000592:standards; D012720:Severity of Illness Index
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists